About Us
About Company
Innovative Biotechnology
AEOLUS is a pioneering biotechnology company dedicated to transforming drug discovery and development through its advanced organ-on-a-chip platforms. We are committed to recreating human physiological microenvironments to deliver novel insights into disease mechanisms and therapeutic efficacy.
Founded in 2025, AEOLUS serves research institutions, pharmaceutical companies, and hospitals, while also offering online consulting services. Our founder, Yaling Liu, is a Professor of Bioengineering and Mechanical Engineering at Lehigh University in the United States, with more than 16 years of interdisciplinary research experience.
Technological Innovation
Advanced Organ Simulation
Our technology platform creates microscale engineered environments that replicate human organ functions, enabling deeper insights into drug development. Through our research, we uncover fundamental disease mechanisms and therapeutic strategies, driving transformative advances in modern medicine.
By leveraging advanced organ-on-a-chip technologies, our team is dedicated to developing innovative solutions that advance medical science. Our research outcomes are shaping the future of drug development and enabling more effective therapies for patients.